Werewolf Therapeutics, Inc.

Historical 13F Holders

Symbol
HOWL
CUSIP
95075A107
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 95075A107 since 12/18/2024, largest first.

Filer % of Class Filed
Balyasny Asset Management L.P. 13G
6.3% 11/16/2026
Event 9/30/2026
Moll Peter 13G 5.2% 9/21/2026
Event 9/18/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
RA Capital Management, L.P. 13D/A
4.1% 7/2/2026
Event 6/30/2026
MPM BioVentures 2014, L.P. 13D/A
3.8% 5/12/2026
Event 5/8/2026
Longwood Fund III, L.P. 13G/A
3.5% 2/11/2026
Event 12/31/2025
PFM Health Sciences, LP 13G/A
0.9% 8/14/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 47 12.9 M $11.9M
2026 Q2 46 10.9 M $3.91M
2026 Q1 48 14.0 M $11.7M
2025 Q4 51 14.7 M $9.34M
2025 Q3 62 21.1 M $41.6M
2025 Q2 66 22.3 M $24.3M
2025 Q1 72 27.4 M $26.7M
2024 Q4 76 28.2 M $41.7M
2024 Q3 70 32.2 M $68.2M
2024 Q2 72 32.5 M $79.2M
2024 Q1 62 32.3 M $209M
2023 Q4 42 27.7 M $107M
2023 Q3 36 23.9 M $51.1M
2023 Q2 37 24.0 M $73.3M
2023 Q1 39 24.0 M $62.5M
2022 Q4 40 20.9 M $42.8M
2022 Q3 45 21.0 M $94.5M
2022 Q2 47 19.1 M $78.0M
2022 Q1 50 19.0 M $84.3M
2021 Q4 52 19.1 M $228M
2021 Q3 43 19.0 M $326M
2021 Q2 46 19.8 M $344M